A phase II trial of tegafur-uracil plus leucovorin (LV) in the treatment of advanced biliary tract carcinomas.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 12949062)

Published in Jpn J Clin Oncol on July 01, 2003

Authors

Jen-Shi Chen1, Tsai-Shen Yang, Yung-Chang Lin, Yi-Yin Jan

Author Affiliations

1: Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan. fong0301@ms18.hinet.net

Articles by these authors

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol (2008) 15.17

Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer. J Clin Oncol (2008) 5.78

Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol (2005) 3.30

Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia. J Clin Oncol (2013) 2.44

Endotoxemia contributes to the immune paralysis in patients with cirrhosis. J Hepatol (2007) 1.90

Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: a multicenter phase II study. Oncology (2013) 1.70

Aggressive surgical approach for patients with T4 gastric carcinoma: promise or myth? Ann Surg Oncol (2011) 1.65

Osteonecrosis of the tibia associated with imatinib in metastatic GI stromal tumor. J Clin Oncol (2013) 1.52

Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases. J Gastroenterol (2004) 1.46

Cisplatin, tegafur-uracil and leucovorin plus mitomycin C: an acceptably effective and toxic regimen for patients with recurrent or metastatic nasopharyngeal carcinoma. Biomed J (2013) 1.43

Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma. Carcinogenesis (2003) 1.40

Primary angiosarcoma of the spleen. J Surg Oncol (2005) 1.37

Successful laparoscopic management for cholecystoenteric fistula. World J Gastroenterol (2006) 1.36

Cholangiographic spectrum of intraductal papillary mucinous neoplasm of the bile ducts. Ann Surg (2006) 1.36

Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI. Breast Cancer Res Treat (2003) 1.34

Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi. World J Surg (2004) 1.28

Management and outcome of bleeding pseudoaneurysm associated with chronic pancreatitis. BMC Gastroenterol (2006) 1.23

Adenosquamous/squamous cell carcinoma of the gallbladder. J Surg Oncol (2007) 1.16

Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate. BMC Gastroenterol (2006) 1.14

Clinicopathological analysis of cystic duct carcinoma. Hepatogastroenterology (2005) 1.13

Clinicopathologic study of node-negative advanced gastric cancer and analysis of factors predicting its recurrence and prognosis. Am J Surg (2012) 1.13

Splenic angiosarcoma metastasis to small bowel presented with gastrointestinal bleeding. World J Gastroenterol (2005) 1.12

Kinase mutations and imatinib mesylate response for 64 Taiwanese with advanced GIST: preliminary experience from Chang Gung Memorial Hospital. Ann Surg Oncol (2006) 1.11

Correct diagnosis and successful treatment for pericardial effusion due to toothpick injury: a case report and literature review. World J Gastroenterol (2007) 1.10

Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma. Ann Surg Oncol (2004) 1.09

Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis. Lab Invest (2004) 1.09

Perforation through small bowel malignant tumors. J Gastrointest Surg (2005) 1.08

Twisting bilayer graphene superlattices. ACS Nano (2013) 1.08

Resectable gastric cancer: operative mortality and survival analysis. Chang Gung Med J (2002) 1.05

Adenosquamous carcinoma of the pancreas. Digestion (2005) 1.05

Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions. Hepatology (2005) 1.05

Primary angiosarcoma of the spleen in a child with long-term survival. Pediatr Surg Int (2007) 1.05

Impact of HER-2 overexpression/amplification on the prognosis of gastric cancer patients undergoing resection: a single-center study of 1,036 patients. Oncologist (2011) 1.04

Surgical management of gallbladder sarcomatoid carcinoma. World J Gastroenterol (2009) 1.04

Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis. World J Surg (2006) 1.03

Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells. Cancer Res (2012) 1.03

The indispensable role of CCR5 for in vivo suppressor function of tumor-derived CD103+ effector/memory regulatory T cells. J Immunol (2012) 1.03

Single-centre results of treatment of retroperitoneal and mesenteric cystic lymphangiomas. Dig Surg (2007) 1.03

Clinicopathologic features and outcomes following surgery for pancreatic adenosquamous carcinoma. World J Surg Oncol (2008) 1.03

Malignant melanoma in Taiwan: a prognostic study of 181 cases. Melanoma Res (2004) 1.02

Standard radical gastrectomy in octogenarians and nonagenarians with gastric cancer: are short-term surgical results and long-term survival substantial? J Gastrointest Surg (2012) 1.02

Surgical management in metastatic gastrointestinal stromal tumor (GIST) patients after imatinib mesylate treatment. J Surg Oncol (2010) 1.02

Endoscopic retrograde cholangiography in the diagnosis and treatment of mucobilia. Scand J Gastroenterol (2008) 1.01

Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy. Ann Surg Oncol (2009) 1.00

Timing of mortality in severe acute pancreatitis: experience from 643 patients. World J Gastroenterol (2007) 1.00

Clinicopathological study of solid and pseudopapillary tumor of pancreas: emphasis on magnetic resonance imaging findings. World J Gastroenterol (2007) 0.99

Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver. Hum Pathol (2002) 0.98

Laparoscopic resection of gastrointestinal stromal tumors: safe, efficient, and comparable oncologic outcomes. J Laparoendosc Adv Surg Tech A (2012) 0.96

Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma. Oncotarget (2014) 0.95

Sunitinib for Taiwanese patients with gastrointestinal stromal tumor after imatinib treatment failure or intolerance. World J Gastroenterol (2011) 0.94

Prognosis of breast cancer after supraclavicular lymph node metastasis: not a distant metastasis. Ann Surg Oncol (2006) 0.94

Imatinib Mesylate for Patients with Recurrent or Metastatic Gastrointestinal Stromal Tumors Expressing KIT: A Decade Experience from Taiwan. Transl Oncol (2011) 0.93

Local anesthesia with ropivacaine for patients undergoing laparoscopic cholecystectomy. World J Gastroenterol (2009) 0.93

Phosphorylated mTOR expression correlates with poor outcome in early-stage triple negative breast carcinomas. Int J Clin Exp Pathol (2012) 0.92

Cisplatin-related hiccups: male predominance, induction by dexamethasone, and protection against nausea and vomiting. J Pain Symptom Manage (2005) 0.92

Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-beta1 by overexpression of cyclin D1. Lab Invest (2005) 0.91

Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma. Arch Surg (2005) 0.90

Tumor necrosis factor alpha promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2. Cancer Lett (2005) 0.90

Effects of massage on pain, mood status, relaxation, and sleep in Taiwanese patients with metastatic bone pain: a randomized clinical trial. Pain (2011) 0.90

Early signet ring cell gastric cancer. Dig Dis Sci (2010) 0.89

Benefits of palliative surgery for far-advanced gastric cancer. Chang Gung Med J (2002) 0.89

Pain relief from combined wound and intraperitoneal local anesthesia for patients who undergo laparoscopic cholecystectomy. BMC Surg (2014) 0.89

Endo-GIA for ligation of dilated cystic duct during laparoscopic cholecystectomy: an alternative, novel, and easy method. J Laparoendosc Adv Surg Tech A (2004) 0.89

Changes and predictors of unmet supportive care needs in Taiwanese women with newly diagnosed breast cancer. Oncol Nurs Forum (2012) 0.88

Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling. Int J Oncol (2013) 0.88

High mobility flexible graphene field-effect transistors with self-healing gate dielectrics. ACS Nano (2012) 0.88

K-ras mutation is strongly associated with perineural invasion and represents an independent prognostic factor of intrahepatic cholangiocarcinoma after hepatectomy. Ann Surg Oncol (2012) 0.88

Assessing the feasibility of wastewater recycling and treatment efficiency of wastewater treatment units. Environ Monit Assess (2007) 0.87

Prognosis and feasibility of en-bloc vascular resection in stage II pancreatic adenocarcinoma. World J Gastroenterol (2010) 0.87

Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer. World J Surg Oncol (2012) 0.87

Small invasive breast carcinomas in Taiwanese women. Ann Surg Oncol (2003) 0.87

Gallbladder carcinoma with biliary invasion: clinical analysis of the differences from nonbiliary invasion. World J Surg (2005) 0.87

Influence of age on surgical treatment of peripheral cholangiocarcinoma. Am J Surg (2004) 0.86

Isolated pancreatic metastasis from rectal cancer: a case report and review of literature. World J Surg Oncol (2010) 0.86

LAP+CD4+ T cells are suppressors accumulated in the tumor sites and associated with the progression of colorectal cancer. Clin Cancer Res (2012) 0.86

Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus. Ann Surg (2014) 0.86

Lower gastrointestinal bleeding due to small bowel metastasis from leiomyosarcoma in the tibia. Chang Gung Med J (2006) 0.86

Prognostic analysis of patients with pancreatic head adenocarcinoma less than 2 cm undergoing resection. World J Gastroenterol (2009) 0.86

Water quality parameters associated with prevalence of Legionella in hot spring facility water bodies. Water Res (2010) 0.86

Evidence for active atomic defects in monolayer hexagonal boron nitride: a new mechanism of plasticity in two-dimensional materials. Nano Lett (2014) 0.85

Oral inoculation of probiotics Lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extra-intestinal tissue. Br J Nutr (2011) 0.85

Animal PET for thioacetamide-induced rat cholangiocarcinoma: a novel and reliable platform. Mol Imaging Biol (2008) 0.85

Using indocyanine green test to avoid post-hepatectomy liver dysfunction. Chang Gung Med J (2007) 0.84

Treatment of patients with advanced gastrointestinal stromal tumor of small bowel: implications of imatinib mesylate. World J Gastroenterol (2006) 0.84

Clinical practice guidelines for patients with gastrointestinal stromal tumor in Taiwan. World J Surg Oncol (2012) 0.84

The role of parenteral glutamine supplement for surgical patient perioperatively: result of a single center, prospective and controlled study. Langenbecks Arch Surg (2008) 0.84

Prognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomy. Oncol Rep (2009) 0.84

Allyl isothiocyanate triggers G2/M phase arrest and apoptosis in human brain malignant glioma GBM 8401 cells through a mitochondria-dependent pathway. Oncol Rep (2010) 0.84

AKT serine/threonine protein kinase modulates bufalin-triggered intrinsic pathway of apoptosis in CAL 27 human oral cancer cells. Int J Oncol (2012) 0.84

No overall increased risk of cancer in patients with rheumatoid arthritis: a nationwide dynamic cohort study in Taiwan. Rheumatol Int (2014) 0.83

Intrahepatic segmental bile duct patterns in hepatolithiasis: a comparative cholangiographic study between Taiwan and Japan. J Hepatobiliary Pancreat Surg (2003) 0.83

Adenosquamous carcinoma of the liver: clinicopathologic features in 12 patients and review of the literature. Int Surg (2002) 0.83

Primary squamous cell carcinoma of the liver: a successful surgically treated case. World J Gastroenterol (2006) 0.83

Laparoscopic cholecystectomy for gallbladder disease in patients with severe cardiovascular disease. World J Surg (2009) 0.83

Remote catalyzation for direct formation of graphene layers on oxides. Nano Lett (2012) 0.83

Ectopic pancreas with gastric outlet obstruction: report of two cases and literature review. Chang Gung Med J (2002) 0.83

Factors influencing long-term survival in patients with T3 gallbladder adenocarcinoma. Digestion (2009) 0.83

Pyogenic liver abscess as a warning sign for primary liver cancer: a nationwide population-based study. Asian Pac J Cancer Prev (2013) 0.83

Improved hepatocyte function of future liver remnant of cirrhotic rats after portal vein ligation: a bonus other than volume shifting. Surgery (2009) 0.82